US House Oversight - Health Care and Financial Services - Subcommittee Hearing
(July 27, 2023) - Video - US House Oversight

United States House Committee on Oversight and Accountability Health Care and Financial Services Subcommittee (US House Oversight - Health Care and Financial Services)

Video - YouTube

Source

https://www.youtube.com/watch?v=uGaYuP5EqwQ

Information Set Membership

US House Oversight - Health Care and Financial Services - Subcommittee Hearing (July 27, 2023) - Information Set
US House Oversight - Health Care and Financial Services - Subcommittee Hearing (July 27, 2023) - Segment - 01 - Welcome - Lisa McClain
US House Oversight - Health Care and Financial Services - Subcommittee Hearing (July 27, 2023) - Segment - 02 - Opening Statement - Lisa McClain
US House Oversight - Health Care and Financial Services - Subcommittee Hearing (July 27, 2023) - Segment - 03 - Opening Statement - Katie Porter
US House Oversight - Health Care and Financial Services - Subcommittee Hearing (July 27, 2023) - Segment - 04 - Opening Statement - James Comer
US House Oversight - Health Care and Financial Services - Subcommittee Hearing (July 27, 2023) - Segment - 05 - Opening Statement - Jamie Raskin
US House Oversight - Health Care and Financial Services - Subcommittee Hearing (July 27, 2023) - Segment - 06 - Introduction - Jonathan Miller
US House Oversight - Health Care and Financial Services - Subcommittee Hearing (July 27, 2023) - Segment - 07 - Introduction - Rayetta Henderson
US House Oversight - Health Care and Financial Services - Subcommittee Hearing (July 27, 2023) - Segment - 08 - Introduction - Richard Badaracco
US House Oversight - Health Care and Financial Services - Subcommittee Hearing (July 27, 2023) - Segment - 09 - Introduction - Gillian Schauer
US House Oversight - Health Care and Financial Services - Subcommittee Hearing (July 27, 2023) - Segment - 10 - Testimony - Introduction - Lisa McClain
US House Oversight - Health Care and Financial Services - Subcommittee Hearing (July 27, 2023) - Segment - 11 - Testimony - Jonathan Miller
US House Oversight - Health Care and Financial Services - Subcommittee Hearing (July 27, 2023) - Segment - 12 - Testimony - Rayetta Henderson
US House Oversight - Health Care and Financial Services - Subcommittee Hearing (July 27, 2023) - Segment - 13 - Testimony - Richard Badaracco
US House Oversight - Health Care and Financial Services - Subcommittee Hearing (July 27, 2023) - Segment - 14 - Testimony - Gillian Schauer
US House Oversight - Health Care and Financial Services - Subcommittee Hearing (July 27, 2023) - Segment - 15 - Testimony - Jonathan Miller - Question - CBD Market Impacts - James Comer
US House Oversight - Health Care and Financial Services - Subcommittee Hearing (July 27, 2023) - Segment - 16 - Testimony - Rayetta Henderson - Question - Scientific Studies - James Comer
US House Oversight - Health Care and Financial Services - Subcommittee Hearing (July 27, 2023) - Segment - 17 - Testimony - Jonathan Miller - Question - FDA Critique - James Comer
US House Oversight - Health Care and Financial Services - Subcommittee Hearing (July 27, 2023) - Segment - 18 - Testimony - Richard Badaracco - Question - Youth Access - James Comer
US House Oversight - Health Care and Financial Services - Subcommittee Hearing (July 27, 2023) - Segment - 19 - Addition to Public Record - Katie Porter
US House Oversight - Health Care and Financial Services - Subcommittee Hearing (July 27, 2023) - Segment - 20 - Statement - Summer Lee
US House Oversight - Health Care and Financial Services - Subcommittee Hearing (July 27, 2023) - Segment - 21 - Testimony - Gillian Schauer - Question - Self-Regulation - Summer Lee
US House Oversight - Health Care and Financial Services - Subcommittee Hearing (July 27, 2023) - Segment - 22 - Testimony - Jonathan Miller - Question - DEI - Summer Lee
US House Oversight - Health Care and Financial Services - Subcommittee Hearing (July 27, 2023) - Segment - 23 - Recess
US House Oversight - Health Care and Financial Services - Subcommittee Hearing (July 27, 2023) - Segment - 24 - Testimony - Jonathan Miller - Question - Legislative Suggestions - Glenn Grothman
US House Oversight - Health Care and Financial Services - Subcommittee Hearing (July 27, 2023) - Segment - 25 - Testimony - Richard Badaracco - Question - Hemp-Derived Product Legality - Glenn Grothman
US House Oversight - Health Care and Financial Services - Subcommittee Hearing (July 27, 2023) - Segment - 26 - Testimony - Jonathan Miller - Question - Intoxicating Hemp-Derived Cannabinoid Market Size - Glenn Grothman
US House Oversight - Health Care and Financial Services - Subcommittee Hearing (July 27, 2023) - Segment - 27 - Testimony - Richard Badaracco - Question - Risks of Hemp-Derived Cannabinoids - Virginia Foxx
US House Oversight - Health Care and Financial Services - Subcommittee Hearing (July 27, 2023) - Segment - 28 - Testimony - Jonathan Miller - Question - Hemp-Derived Cannabinoid Legality - Virginia Foxx
US House Oversight - Health Care and Financial Services - Subcommittee Hearing (July 27, 2023) - Segment - 29 - Testimony - Jonathan Miller - Question - PAL and Lobbying - Lisa McClain
US House Oversight - Health Care and Financial Services - Subcommittee Hearing (July 27, 2023) - Segment - 30 - Closing Statement - Lisa McClain
US House Oversight - Health Care and Financial Services - Subcommittee Hearing (July 27, 2023) - Segment - 31 - Wrapping Up - Lisa McClain